Skip to main content

HALAVEN-eribulin mesilate 1 mg/2 mL solution for injection glass vial (Eisai Australia Pty Ltd)

Product name
HALAVEN-eribulin mesilate 1 mg/2 mL solution for injection glass vial
Decision type
Cancelled under s30(2)(f) of the Act
Date of effect
Decision status
Internal review revoked the cancellation decision - effective from 29 May 2014

Help us improve the Therapeutic Goods Administration site